Dipterocarpus conformis

restor3d Completes Acquisition of Conformis

Retrieved on: 
Tuesday, September 5, 2023
3D, Joint, Surgeon, Spine, Dipterocarpus conformis, Acquisition, Shoulder, Patient, Medical device

DURHAM, North Carolina and BILLERICA, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis’ stockholders at a special meeting held on August 31, 2023.

Key Points: 
  • DURHAM, North Carolina and BILLERICA, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. announced today that restor3d has completed its previously announced acquisition of Conformis following the approval of Conformis’ stockholders at a special meeting held on August 31, 2023.
  • In connection with the completion of the acquisition, shares of Conformis’ common stock ceased trading on the NASDAQ prior to the opening of the NASDAQ on September 5, 2023.
  • “We are extremely excited to complete this important transaction and look forward to leveraging our combined portfolio to deliver personalized orthopedic solutions for the whole human body,” said J. Kurt Jacobus, CEO of restor3d.
  • With existing expertise in 3D printing of osseointegrative biomedical materials, biomechanics modeling, artificial-intelligence-based planning and design automation tools, the addition of Conformis propels the scalable future of best-in-class personalized device solutions to present day.

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d

Retrieved on: 
Wednesday, August 23, 2023
Dipterocarpus conformis, Eastern Time Zone, Telephone, Glass Lewis, Internet, Knee, ISS, Holding company

BILLERICA, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”), have each recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d.

Key Points: 
  • BILLERICA, Mass., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firms, Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”), have each recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d.
  • As previously announced, under the terms of the definitive merger agreement, restor3d will acquire all outstanding shares of common stock of Conformis for $2.27 per share in an all cash transaction.
  • Conformis is pleased that ISS and Glass Lewis share its belief that the proposed merger with restor3d is in the best interests of all Conformis stockholders.
  • The Company encourages stockholders to submit their proxy as soon as possible, whether over the Internet, by telephone or by mail.

Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d

Retrieved on: 
Monday, August 21, 2023
Dipterocarpus conformis, Telephone, Eastern Time Zone, Internet, Knee, ISS, Holding company

BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), has recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d.

Key Points: 
  • BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a leading medical technology company featuring personalized knee and hip replacement products, announced today that leading independent proxy advisory firm, Institutional Shareholder Services Inc. (“ISS”), has recommended that Conformis stockholders vote “FOR” the pending merger transaction with restor3d.
  • As previously announced, under the terms of the definitive merger agreement, restor3d will acquire all outstanding shares of common stock of Conformis for $2.27 per share in an all cash transaction.
  • Conformis is pleased that ISS shares its belief that the proposed merger with restor3d is in the best interests of all Conformis stockholders.
  • The Company encourages stockholders to submit their proxy as soon as possible, whether over the Internet, by telephone or by mail.

Moore Kuehn Encourages TRTN, CFMS, AMED, and NEX Investors to Contact Law Firm

Retrieved on: 
Wednesday, August 9, 2023
PLLC, Optum, Dipterocarpus conformis, Triton International, Wall Street, Patterson-UTI, Fraud, Brookfield Infrastructure Partners, Security (finance), Bank, Amedisys

Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.

Key Points: 
  • Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies.
  • Under the proposed transaction, Triton International shareholders will receive $68.50 in cash and $16.50 in BIPC class A exchangeable shares per share.
  • Moore Kuehn encourages shareholders who would like to discuss their rights to contact Justin Kuehn, Esq.
  • Moore Kuehn is a 5-star Google client-rated New York City law firm with attorneys representing investors and consumers in litigation involving securities laws, fraud, breaches of fiduciary duties, and other claims.

Conformis Reports Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 2, 2023
Dipterocarpus conformis, Marketing, GAAP, Translation, Research, End-user license agreement, Music, Pharmaceutical industry, Cryptocurrency, Bank

Product gross profit margin was 38% in the second quarter of 2023, compared to 35% in the same period last year.

Key Points: 
  • Product gross profit margin was 38% in the second quarter of 2023, compared to 35% in the same period last year.
  • Total gross profit decreased $3.6 million to $1.8 million, or 14% of revenue, for the second quarter of 2023, compared to $5.5 million, or 36% of revenue, in the same period last year.
  • Cash and cash equivalents totaled $26.2 million as of June 30, 2023, compared to $37.8 million as of March 31, 2023.
  • In addition to disclosing financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company provides certain information regarding the Company's financial results or projected financial results on a non-GAAP "constant currency basis."

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEWR, SURF, CFMS

Retrieved on: 
Tuesday, August 1, 2023
Sale, Dipterocarpus conformis, Fraud, NYSE, Advertising, Francisco Partners, Security (finance), New Relic

If you are a New Relic shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a New Relic shareholder, click here to learn more about your rights and options .
  • If you are a Conformis shareholder, click here to learn more about your rights and options .
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – AJX, PDCE, CFMS, SGTX

Retrieved on: 
Tuesday, July 25, 2023
Eli Lilly and Company, AJX, Empire, Chevron Corporation, Sale, Dipterocarpus conformis, Monteverde, CFMS, Therapy, NYSE, Security (finance)

Under the terms of the agreement, AJX shareholders are expected to receive 0.5308 shares of Ellington per share they own.

Key Points: 
  • Under the terms of the agreement, AJX shareholders are expected to receive 0.5308 shares of Ellington per share they own.
  • It is free and there is no cost or obligation to you.
  • PDC Energy, Inc. (NASDAQ: PDCE ), relating to its proposed merger with Chevron Corp.
  • Under the terms of the agreement, PDCE shareholders are expected to receive 0.4638 shares of Chevron per share they own.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – PDCE, SGTX, CFMS, SYNH

Retrieved on: 
Monday, July 17, 2023
Eli Lilly and Company, Veritas Capital, Empire, Chevron Corporation, Sale, Elliott Investment Management, Dipterocarpus conformis, Monteverde, CFMS, Therapy, Security (finance)

Under the terms of the agreement, PDCE shareholders are expected to receive 0.4638 shares of Chevron per share they own.

Key Points: 
  • Under the terms of the agreement, PDCE shareholders are expected to receive 0.4638 shares of Chevron per share they own.
  • It is free and there is no cost or obligation to you.
  • Syneos Health, Inc. (NASDAQ: SYNH ), relating to its proposed sale to Elliott Investment Management, Patient Square Capital, and Veritas Capital.
  • Under the terms of the agreement, SYNH shareholders are expected to receive $43.00 in cash per share they own.

ALERT: The M&A Class Action Firm Continues Investigating the Merger – CFMS, PRTK, NETI, WMC

Retrieved on: 
Tuesday, July 11, 2023
Cadell Training Centre, Empire, Sale, Eneti, Novo Holdings A/S, Dipterocarpus conformis, WMC, Monteverde, CFMS, NYSE, Security (finance)

Under the terms of the agreement, CFMS shareholders are expected to receive $2.27 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, CFMS shareholders are expected to receive $2.27 in cash per share they own.
  • Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK ), relating to its proposed sale to Gurnet Point Capital and Novo Holdings A/S.
  • Under the terms of the agreement, NETI shareholders are expected to receive 3.409 shares of Cadeler per share they own.
  • Western Asset Mortgage Capital Corp. (NYSE: WMC ), relating to its proposed merger with Terra Property Trust, Inc. Click here for more information: https://monteverdelaw.com/case/western-asset-mortgage-capital-corp .

ALERT: The M&A Class Action Firm Continues Investigating the Merger – KLR, CFMS, NETI, WMC

Retrieved on: 
Thursday, June 29, 2023
KLR, Kaleyra, Cadell Training Centre, Empire, Sale, Tata Communications, Eneti, Dipterocarpus conformis, WMC, Monteverde, CFMS, NYSE, Security (finance)

Under the terms of the agreement, KLR shareholders will receive $7.25 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, KLR shareholders will receive $7.25 in cash per share they own.
  • Under the terms of the agreement, CFMS shareholders are expected to receive $2.27 in cash per share they own.
  • Under the terms of the agreement, NETI shareholders are expected to receive 3.409 shares of Cadeler per share they own.
  • Western Asset Mortgage Capital Corp. (NYSE: WMC ), relating to its proposed merger with Terra Property Trust, Inc. Click here for more information: https://monteverdelaw.com/case/western-asset-mortgage-capital-corp .